Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 22, 2019
Effects of Water Loading on Observed and Predicted Plasma Sodium, and Fluid and Urine Cation Excretion in Healthy Individuals
Rosa D Wouda, Shosha E I Dekker, Joelle Reijm, et al.
Plos One
|
May 23, 2020
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
Shosha E I Dekker, Aswin Verhoeven, Darius Soonawala, et al.
American Journal of Nephrology
|
May 25, 2022
Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
Shosha E I Dekker, Aswin Verhoeven, Daria Frey, et al.
European Journal of Clinical Investigation
|
December 10, 2023
Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide
Shosha E I Dekker, Jörgen Bierau, Martin Giera, et al.
Kidney International Reports
|
June 14, 2019
Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
Shosha E I Dekker, L Renee Ruhaak, Fred P H T M Romijn, et al.
The Journal of Antimicrobial Chemotherapy
|
May 22, 2020
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
Lucas H P Bernts, Shosha E I Dekker, Darius Soonawala, et al.
World Journal of Urology
|
March 17, 2023
The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease
Paul Geertsema, Ron T Gansevoort, Lisanne P J Brenkman, et al.
JAMA
|
November 14, 2018
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial
Esther Meijer, Folkert W Visser, Rene M M van Aerts, et al.
Gastroenterology
|
April 26, 2019
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease
Rene M M van Aerts, Wietske Kievit, Hedwig M A D'Agnolo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 22, 2019
Effects of Water Loading on Observed and Predicted Plasma Sodium, and Fluid and Urine Cation Excretion in Healthy Individuals
Rosa D Wouda, Shosha E I Dekker, Joelle Reijm, et al.
Plos One
|
May 23, 2020
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
Shosha E I Dekker, Aswin Verhoeven, Darius Soonawala, et al.
American Journal of Nephrology
|
May 25, 2022
Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
Shosha E I Dekker, Aswin Verhoeven, Daria Frey, et al.
European Journal of Clinical Investigation
|
December 10, 2023
Serum bile acids associate with liver volume in polycystic liver disease and decrease upon treatment with lanreotide
Shosha E I Dekker, Jörgen Bierau, Martin Giera, et al.
Kidney International Reports
|
June 14, 2019
Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
Shosha E I Dekker, L Renee Ruhaak, Fred P H T M Romijn, et al.
The Journal of Antimicrobial Chemotherapy
|
May 22, 2020
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
Lucas H P Bernts, Shosha E I Dekker, Darius Soonawala, et al.
World Journal of Urology
|
March 17, 2023
The impact of pre-transplantation nephrectomy on quality of life in patients with autosomal dominant polycystic kidney disease
Paul Geertsema, Ron T Gansevoort, Lisanne P J Brenkman, et al.
JAMA
|
November 14, 2018
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial
Esther Meijer, Folkert W Visser, Rene M M van Aerts, et al.
Gastroenterology
|
April 26, 2019
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease
Rene M M van Aerts, Wietske Kievit, Hedwig M A D'Agnolo, et al.
Page
of 1